SUMMARY Morphometric methods were used to study the ultrastructure of blood monocytes in 23 patients with Hodgkin's disease, 12 patients with non-Hodgkin's lymphoma, and 20 normal subjects. The results were analysed using both univariate and multivariate methods. Both analyses supported the interpretation that the total mitochondrial contribution to the cellular ultrastructure was less in Hodgkin's disease than in the other two groups, with smaller mitochondrial volume fractions, volumes, and surface areas being found. In the patients with non-Hodgkin's lymphoma univariate analysis suggested that monocyte nuclei were larger, with more euchromatin and a relatively smaller heterochromatin-euchromatin interface; the cell profile area was larger and the surface to volume ratio was smaller compared with normal subjects. Morphological changes have not previously been described in blood monocytes in malignant lymphoma, but they may be the counterpart of the known mononuclear phagocyte dysfunction.
While there is ample evidence of dysfunction of mononuclear phagocytes in malignant disease, there are few reports of changes in their morphology ' and, hitherto, none has been described at the blood monocyte stage. The present investigation was undertaken to see whether any ultrastructural changes could be detected in blood monocytes in patients with malignant lymphoma. Morphometric techniques, similar to those used to quantify features of blood monocytes in normal subjects,2 were used with both univariate and multivariate methods of analysis.
Material and methods
Thirty five patients with malignant lymphoma and 20 normal subjects were studied. Twenty three patients had Hodgkin's disease, of whom 12 were men and 11 were women, with ages ranging from 18 to 70 years (mean (SE) = 39 0 (3 9) years). Of these 23 patients, six had the lymphocyte predominant type of disease, six (all women) the nodular sclerosing type, and 11 the mixed cellularity type; all four disease stages were represented. Twelve patients had non-Hodgkin's lymphoma, of whom five were men and seven were women, with ages ranging from 34 to 75 years (mean (SE) = 54*3 (2.9)). In nine cases the disease was of the follicular centre cell type, and all four disease stages were represented.
Accepted for publication 18 April 1985 Among the normal subjects there were 10 men and 10 women, ages ranging from 17 to 52 years (29-3 (2.2)). All the patients with lymphoma were untreated except for one with Hodgkin's disease, who had been taking prednisolone for some weeks, and one with non-Hodgkin's lymphoma, who had been treated with allopunnol and brufen for four years. One of the patients with Hodgkin's disease had a concurrent carcinoma of the bronchus and one had had a papillary tumour removed from the bladder five days earlier. All the normal subjects were fit and were not taking any drugs.
About 10 ml of venous blood was collected into 5 ml of 6% dextran 150 containing 500 units of pure heparin and gently mixed. Leucocytes were separated, fixed in 1 5% glutaraldehyde in 0 1M (,um2) 280-8 (5-9) 274-8 (7-3) 285-3 (11-9) Nucleus Volume fraction (%) *significant difference from normal at the 0.05 level of probability tsignificant difference from normal at the 0-1 level of probability tsignificant difference between Hodgkin's and non-Hodgkin's lymphoma at the 0-05 level of probability §significant difference between Hodgkin's and non-Hodgkin's lymphoma at the 0-1 level of probability. Multivariate analysis: ¶significant differences from both other groups.
Both the univariate and multivariate analysis of the results ( Table) support the interpretation that the total mitochondrial contribution to the cellular ultrastructure was significantly smaller in patients with Hodgkin' s disease than in the other two groups, the reduction being of the order of 10%. The values given in the Table provide no evidence that this was due to changes in size (profile area) or configuration (surface to volume ratio), and therefore suggest that it was more likely to be due to a reduction in the number of mitochondria. It may be relevant that previous studies have found some functional differences in the blood monocytes of patients with Hodgkin's disease'0'2 and it seems reasonable to suggest that the reduction in quantitative values for mitochondria noted here may be associated with a reduced energy potential in the monocyte with consequent effect on function. Further investigation of this point would appear important.
In the patients with non-Hodgkin's lymphoma univariate analysis of the results ( Table) supports the interpretation that, compared with those of the other groups, the nuclei were increased in size, with more euchromatin and a smaller heterochromatineuchromatin interface per unit volume; the cell profile area was larger and the cell surface to volume ratio was smaller compared with normal subjects.
By considering surface areas of spheres of equivalent volumes, we showed that the lower cell surface to volume ratio was not entirely due to the larger cell size, which implies that there was also a decrease in surface irregularity. All these changes would be consistent with enhanced monocyte activation. On multivariate analysis, however, the null hypothesis could not be rejected in relation to differences between the variable groups chosen. While caution must therefore be exercised in drawing inferences from the individual differences in the Table, it is pertinent to note that in skin window studies the macrophages of patients with lymphoma were bigger than normal, with larger and rounder nuclei, these features being particularly pronounced in patients with non-Hodgkin's lymphoma. '3 Knowledge of the spatial organisation within cells Sokol, Hudson, Wales, James 906 
